X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
coronary heart disease (7) 7
aged (5) 5
female (5) 5
humans (5) 5
male (5) 5
middle aged (5) 5
risk factors (5) 5
care and treatment (4) 4
coronary disease (4) 4
coronary disease - mortality (4) 4
index medicus (4) 4
inflammation (4) 4
lipoprotein (4) 4
myocardial infarction (4) 4
prospective studies (4) 4
1-alkyl-2-acetylglycerophosphocholine esterase - metabolism (3) 3
atherosclerosis (3) 3
benzaldehydes - administration & dosage (3) 3
benzaldehydes - adverse effects (3) 3
biological markers (3) 3
biomarkers (3) 3
cardiac & cardiovascular systems (3) 3
cardiovascular disease (3) 3
clinical medicine (3) 3
clinical trials (3) 3
coronary artery disease (3) 3
coronary disease - drug therapy (3) 3
double-blind method (3) 3
klinisk medicin (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
original research (3) 3
oximes - administration & dosage (3) 3
oximes - adverse effects (3) 3
phospholipase a2 inhibitors - administration & dosage (3) 3
phospholipase a2 inhibitors - adverse effects (3) 3
research (3) 3
activating-factor acetylhydrolase (2) 2
atherosclerotic plaque (2) 2
biomarkers - metabolism (2) 2
cardiac and cardiovascular systems (2) 2
coronary disease - enzymology (2) 2
diabetes (2) 2
kardiologi (2) 2
lipids (2) 2
myocardial infarction - etiology (2) 2
myocardial infarction - mortality (2) 2
pharmacology (2) 2
prognosis (2) 2
stability investigators (2) 2
stroke (2) 2
stroke - etiology (2) 2
stroke - mortality (2) 2
treatment (2) 2
trial (2) 2
usage (2) 2
11 medical and health sciences (1) 1
abridged index medicus (1) 1
acute coronary syndromes (1) 1
adult (1) 1
aging (1) 1
angina (1) 1
antigens, cd - metabolism (1) 1
antigens, differentiation, myelomonocytic - metabolism (1) 1
apoptosis (1) 1
arteriosclerosis (1) 1
artery-disease (1) 1
assaigs clínics de medicaments (1) 1
atherosclerosis - metabolism (1) 1
benzaldehydes (1) 1
beta-blocking drug (1) 1
biomarkers - blood (1) 1
c-reactive protein (1) 1
cancer (1) 1
cardiovascular agents (1) 1
cardiovascular diseases (1) 1
cardiovascular outcomes (1) 1
carotid arteries - metabolism (1) 1
carotid artery (1) 1
carotid stenosis - drug therapy (1) 1
carotid stenosis - metabolism (1) 1
cerebral infarction (1) 1
clinical-outcomes (1) 1
cognitive impairment (1) 1
coronary artery disease - complications (1) 1
coronary artery disease - drug therapy (1) 1
coronary disease - blood (1) 1
coronary disease - diagnosis (1) 1
coronary diseases (1) 1
darapladib (1) 1
death (1) 1
dementia (1) 1
diagnosis (1) 1
disease progression (1) 1
dosage and administration (1) 1
drug testing (1) 1
drug therapy (1) 1
endarterectomy, carotid (1) 1
epidemiology (1) 1
events (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Chemistry, ISSN 0009-9147, 01/2017, Volume 63, Issue 1, pp. 325 - 333
Journal Article
by White, Harvey D and Held, Claes and Stewart, Ralph and Tarka, Elizabeth and Brown, Rebekkah and Davies, Richard Y and Budaj, Anzej and Harrington, Robert A and Steg, P. Gabriel and Ardissino, Diego and Armstrong, Paul W and Avezum, Alvaro and Aylward, Philip E and Bryce, Alfonso and Chen, Hong and Chen, Ming-Fong and Corbalan, Ramon and Dalby, Anthony J and Danchin, Nicolas and de Winter, Robbert J and Denchev, Stefan and Diaz, Rafael and Elisaf, Moses and Flather, Marcus D and Goudev, Assen R and Granger, Christopher B and Grinfeld, Liliana and Hochman, Judith S and Husted, Steen and Kim, Hyo-Soo and Koenig, Wolfgang and Linhart, Ales and Lonn, Eva and López-Sendón, José and Manolis, Athanasios J and Mohler, Emile R and Nicolau, José C and Pais, Prem and Parkhomenko, Alexander and Pedersen, Terje R and Pella, Daniel and Ramos-Corrales, Marco A and Ruda, Mikhail and Sereg, Mátyás and Siddique, Saulat and Sinnaeve, Peter and Smith, Peter and Sritara, Piyamitr and Swart, Henk P and Sy, Rody G and Teramoto, Tamio and Tse, Hung-Fat and Watson, David and Weaver, W. Douglas and Weiss, Robert and Viigimaa, Margus and Vinereanu, gos and Zhu, Junren and Cannon, Christopher P and Wallentin, Lars and Steg, Ph Gabriel and Bucan, Olga and Elfström, Charlotta and Hegg, Lisa and Jarosz, Marie and Krug-Gourley, Sue and Rudman, Jerry and Collins, Rory and Anderson, Jeffrey and DeMets, David and Ganz, Peter and Sandercock, Peter and Weber, Michael and Fisher, Marian and Buhr, Kevin and Diegel, Scott and Schultz, Melissa and Mahaffey, Kenneth W and Alexander, John H and Al-Khatib, Sana and Baron, Tomasz and Bergström, Olle and Bushnell, Cheryl and Christersson, Christina and Eggers, Kai and Fredlund, Bengt-Olov and Hagström, Emil and Hijazi, Ziad and Örndahl, Lovisa Holm and James, Stefan K and Jernberg, Tomas and Johnston, Nina and Lopez, Renato D and Mehta, Rajena H and Newby, Kristin L and Nordmark, Örjan and Oldgren, Jonas and Roe, Matthew T and Saldéen, Katarina and Stenborg, Anna and ... and The STABILITY Investigators and STABILITY Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 04/2019, Volume 8, Issue 7, p. e010641
Background-Vascular risk factors have been associated with differences in cognitive performance in epidemiological studies, but evidence in patients with... 
cognitive impairment | coronary heart disease | Montreal Cognitive Assessment | risk factor | CARDIAC & CARDIOVASCULAR SYSTEMS | DEMENTIA | MOCA | HEALTH | IMPAIRMENT
Journal Article
Atherosclerosis, ISSN 0021-9150, 12/2017, Volume 267, pp. 78 - 89
Lipoprotein-associated phospholipase A (Lp-PLA ), an enzymatic inflammatory biomarker primarily bound to low-density lipoprotein cholesterol, is associated... 
Pathology | Lipoprotein-associated phospholipase A2 | Carotid artery | Statin | Macrophage | Lipoprotein-associated phospholipase A
Journal Article
Atherosclerosis, ISSN 0021-9150, 12/2017, Volume 267, p. 78
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link:... 
Low density lipoproteins | Phospholipases | Macrophages | Statins
Journal Article
Journal of the American Heart Association, ISSN 2047-9980, 06/2016, Volume 5, Issue 6, p. n/a
Background We evaluated lipoprotein‐associated phospholipase A2 (Lp‐PLA2) activity in patients with stable coronary heart disease before and during treatment... 
atherosclerosis | coronary disease | inflammation | lipoprotein | myocardial infarction | Myocardial infarction | Inflammation | Lipoprotein | Coronary disease | Atherosclerosis
Journal Article
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue Suppl_3 Suppl 3, pp. A16755 - A16755
IntroductionClinical practice guidelines have recommended evidence based medicine (EBM) and treatment targets for optimal management of BP, LDL Cholesterol... 
Journal Article
Journal Article
Journal Article
Journal Article
The American Journal of Cardiology, ISSN 0002-9149, 1998, Volume 82, Issue 8, pp. 927 - 931
Carvedilol is a nonselective β-receptor antagonist with vasodilating properties primarily due to selective α-1 antagonism. This 4-treatment, 5- period,... 
CARDIAC & CARDIOVASCULAR SYSTEMS | BETA-BLOCKING DRUG | PECTORIS
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.